Please assess the completion status of the following clinical trial:

Trial Title: Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Participants who are administered with Stelara for the first time for the indication of Crohn's disease in accordance with the label~* Participants must sign a participation agreement/informed consent form (ICF) allowing data collection and source data verification in accordance with local requirements~Exclusion Criteria:~- Have contraindication to Stelara in accordance to the label

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Participants with Crohn's Disease (Type: None): Participants that are diagnosed with Crohn's disease will be observed in this study who are being treated with ustekinumab under real world clinical practice. Only data available per clinical practice will be collected within this study.

Based on this trial design, predict the completion outcome and termination type (if applicable).